CDSCO panel’s nod to Sun Pharma for Rosuvastatin Sprinkle Capsules

Few brands of Rosuvastatin include Intas Pharma's ARVAST tab, Alkem's JUPIROS tab, Lupin's NOVASTAT tab, Cipla's ROSULIP tab etc.

116
CDSCO DCGI FDA

Last Updated on December 22, 2021 by The Health Master

New Delhi: Pharmaceutical major, Sun Pharma, has got the go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to manufacture and market Rosuvastatin Sprinkle Capsules 10 mg/20 mg/40 mg.

This approval came after the firm presented the proposal along with the results of the bioequivalence (BE) study report for Rosuvastatin Sprinkle Capsules.

Bioequivalence studies are special types of studies where two drugs or two sets of formulations of the same drug are compared to show that they have nearly equal bioavailability and pharmacokinetic/pharmacodynamic (PK/PD) parameters.

Rosuvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease, including myocardial infarction and stroke.

Rosuvastatin selectively and competitively binds to and inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a precursor of cholesterol.

Few brands of Rosuvastatin include Intas Pharma’s ARVAST tab, Alkem’s JUPIROS tab, Lupin’s NOVASTAT tab, Cipla’s ROSULIP tab etc.

At a recent SEC meeting for Cardiovascular & Renal, dated 08.12.2021 and 09.12.2021 the committee extensively reviewed Sun Pharma‘s proposal for manufacturing and marketing Rosuvastatin Sprinkle Capsules 10 mg/20mg/40mg.

After detailed deliberation, the committee recommended the grant of permission for the manufacture and marketing of Rosuvastatin Sprinkle Capsules in 10 mg, 20 mg, and 40 mg.

Sun Pharma gets CDSCO panel nod for FDC Brinzolamide, Timolol, Pot Sorbate

CDSCO Panel gives nod to Sun Pharma’s Dapagliflozin, Glimepiride, Metformin FDC

USFDA relaxes restriction on Abortion Pill

Medical Devices: Current scenario and need of the hour

Govt introduces amendment Bill, decriminalising use of biological resources by ‘Vaids’,…

USFDA approved Finasteride, Tadalafil for new treatment for Benign Prostatic Hyperplasia

Govt notifies NIB, Noida as CDL to test Covid-19 vaccines

USFDA issues Form 483 to Alembic Pharma Gujarat plant

FDA Haryana and police unearthed a unit manufacturing spurious cosmetics

In-service Pharmacists authorised to dispense drugs for these 8 common ailments

Recruitment of 87 Drug Inspectors put on hold in Maharashtra

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner